Page last updated: 2024-08-17

fluocinolone acetonide and tretinoin

fluocinolone acetonide has been researched along with tretinoin in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (23.64)	18.7374
1990's	6 (10.91)	18.2507
2000's	16 (29.09)	29.6817
2010's	14 (25.45)	24.3611
2020's	6 (10.91)	2.80

Authors

Authors	Studies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Katoh, F; Yamasaki, H	1
Marian, B	1
Chenicek, KJ; DiGiovanni, J; Kruszewski, FH	1
Pence, BC; Reiners, JJ	1
Hennings, H; Yuspa, SH	1
Baumgarten, IM; Davidson, JS; Harley, EH	1
Ballaron, S; De Young, L	1
Nelson, KG; Slaga, TJ	1
Ballaron, SJ; De Young, LM; Puhvel, SM; Spires, DA; Young, JM	1
Kalimi, GH; Sirsat, SM	1
Fischer, SM; Klein-Szanto, AJ; Major, S; Nelson, K; Slaga, TJ; Weeks, CE	1
Slaga, TJ; Solanki, V	1
Fischer, SM; Klein-Szanto, AJ; Mamrack, M; Nelson, K; Slaga, TJ; Weeks, CE	1
Kim, TW; Smart, RC	1
Colburn, NH; Dong, Z; Lavrovsky, V	1
Birrer, MJ; Colburn, NH; Dong, Z; Matrisian, LM; Watts, RG	1
Buajeeb, W; Kraivaphan, P; Pobrurksa, C	1
Dawson, MI; Dong, Z; Flavell, RA; Huang, C; Ma, WY; Rincon, M	1
Holmgren, A; Kumar, S	1
Castranova, V; Costa, M; Ding, M; Huang, C; Ju, G; Li, J; Shi, X; Vallyathan, V	1
Baumann, L; Jarratt, MM; Jones, T; Lowe, N; Martin, D; Menter, A; Pariser, D; Ramirez, N; Rich, P; Shavin, J; Taylor, SC; Torok, H; Tschen, E; Weiss, J; Wieder, JJ	1
Jones, T; Rich, P; Smith, S; Torok, HM; Tschen, E	1
Grimes, P; Kelly, AP; Torok, H; Willis, I	1
Torok, HM	1
Arellano, I; Hexsel, D; Rendon, M	1
Almeida, AR; Azulay, L; Cestari, TF; Filho, JW; Hassun, K; Hexsel, D; Junqueira, H; Mendes, AM; Rêgo, VR; Viegas, ML	1
de Lourdes Viegas, M; Ferreira Cestari, T; Hassun, K; Sittart, A	1
Adjadj, L; Cestari, T; Hux, M; Rives, VP; Shimizu, MR	1
Grimes, PE	1
Chan, R; Chang, SE; Kerrouche, N; Lee, ES; Lee, MH; Legarda-Montinola, F; Leow, YH; Park, KC; Shek, S; Tay, YK; Thomas, G; Tsai, RY; Tsai, TH; Verallo-Rowell, V	1
Adigun, CG; Pandya, AG	1
Benitez, AL; Bussear, EW; Cardona, LM; Colón, LE; Johnson, LA; Rendon, M	1
Arellano, I; Cestari, T; Hexsel, D; Ortonne, JP	1
Bergstrom, KG; Que, SK	1
Bhawan, J; Byers, HR; Colón, LE; Gottschalk, R; Grimes, P; Guevara, IL; Johnson, LA; Keady, M; Pandya, AG	1
Alikhan, A; Balkrishnan, R; Daly, M; Feldman, SR; Wu, J	1
Jeong, SY; Kim, IH; Kim, WS; Shin, JB; Yeo, UC	1
Bhawan, J; Colón, LE; Gottschalk, RW; Grimes, PE; Guevara, IL; Johnson, LA; Pandya, AG	1
Draelos, Z	1
Colón, LE; Gold, MH; Goldman, MP; Gottschalk, RW; Johnson, LA; Palm, MD; Preston, N	1
Godse, KV; Sakhia, J	1
Arellano, I; Azulay-Abulafia, L; Bezerra Trindade Neto, P; Cestari, T; Hexsel, D; Machado-Pinto, J; Marques-Hassun, K; Muñoz, H; Ocampo-Candiani, J; Paliargues, F; Rego, V; Rivitti-Machado, MC; Sittart, JA; Trindade de Almeida, AR	1
Bahadoran, P; Fontas, E; Kang, HY; Lacour, JP; Ortonne, JP; Passeron, T	1
Dreher, F; Monheit, GD	1
Hexsel, C; Hexsel, D; Porto, MD; Siega, C	1
Fernandes, JD; Hexsel, D; Siega, C; Soirefmann, M	1
Dang, Y; Gong, Z; Lai, W; Li, L; Liu, L; Wang, X; Yang, Q; Zhao, G; Zheng, M; Zou, Y	1
Cabrera-Alonso, R; González, FJ; Guevara, E; Moncada, B; Ramírez-Elías, MG	1
Chang, CC; Chang, TM; Chen, YT; Chiang, HM; Chiu, PC; Huang, YH; Lin, BS; Lin, ET; Lin, HY; Wang, KY; Wang, YJ	1
Andanooru Chandrappa, NK; Banavase Channakeshavaiah, R	1
de Abreu, L; de Barros, MH; Ramírez-Oliveros, JF; Tamler, C; Vilhena, P	1
Jawade, S; Kulkarni, S; Madke, B; Sahu, PJ; Saoji, V; Singh, AL	1
Blicharz, L; Galadari, H; Gold, MH; Goldman, MP; Goldust, M; Kassir, M; Konnikov, N; Mahajan, VK; Patil, A	1
Bagatin, E; de Freitas, ACP; Leonardi, GR; Rigon, RB	1

Reviews

4 review(s) available for fluocinolone acetonide and tretinoin

Article	Year
Specificity and mechanism(s) of promoter inhibitors in multistage promotion. Carcinogenesis; a comprehensive survey, 1982, Volume: 7 Topics: Animals; Carcinogens; Cocarcinogenesis; Diterpenes; Epidermal Cells; Fluocinolone Acetonide; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Phorbol Esters; Polyamines; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin	1982
A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. American journal of clinical dermatology, 2006, Volume: 7, Issue:4 Topics: Administration, Cutaneous; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Time Factors; Tretinoin	2006
Melasma in Latin America: options for therapy and treatment algorithm. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:7 Topics: Algorithms; Drug Therapy, Combination; Evidence-Based Medicine; Fluocinolone Acetonide; Humans; Hydroquinones; Latin America; Melanosis; Quality of Life; Tretinoin	2009
Medical therapies for melasma. Journal of cosmetic dermatology, 2022, Volume: 21, Issue:9 Topics: Adrenal Cortex Hormones; Cosmeceuticals; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Quality of Life; Silicones; Sunscreening Agents; Tranexamic Acid; Treatment Outcome; Tretinoin; Zinc Oxide	2022

Trials

20 trial(s) available for fluocinolone acetonide and tretinoin

Article	Year
Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1997, Volume: 83, Issue:1 Topics: Administration, Oral; Administration, Topical; Adult; Anti-Inflammatory Agents; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Keratolytic Agents; Lichen Planus, Oral; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome; Tretinoin	1997
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis, 2003, Volume: 72, Issue:1 Topics: Administration, Topical; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Middle Aged; Ointments; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin	2003
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis, 2005, Volume: 75, Issue:1 Topics: Antioxidants; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Male; Melanosis; Middle Aged; Ointments; Treatment Outcome; Tretinoin	2005
Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis, 2006, Volume: 77, Issue:3 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Dermatologic Agents; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Prospective Studies; Treatment Outcome; Tretinoin; United States	2006
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. Journal of cosmetic dermatology, 2007, Volume: 6, Issue:1 Topics: Administration, Topical; Adult; Drug Combinations; Emollients; Facial Dermatoses; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin	2007
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:2 Topics: Administration, Topical; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Treatment Outcome; Tretinoin	2007
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. The British journal of dermatology, 2008, Volume: 159, Issue:3 Topics: Administration, Cutaneous; Adult; Analysis of Variance; Asian People; Double-Blind Method; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Patient Satisfaction; Treatment Outcome; Tretinoin	2008
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study. Cutis, 2008, Volume: 82, Issue:5 Topics: Administration, Cutaneous; Adult; Chemexfoliation; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Follow-Up Studies; Glycolates; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Pilot Projects; Severity of Illness Index; Treatment Outcome; Tretinoin	2008
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream. The American Journal of dermatopathology, 2009, Volume: 31, Issue:8 Topics: Administration, Cutaneous; Adult; Atrophy; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Skin; Tretinoin	2009
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:6 Topics: Administration, Topical; Adult; Antioxidants; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Lasers, Solid-State; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin	2010
Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Keratolytic Agents; Low-Level Light Therapy; Male; Melanosis; Middle Aged; Radiation-Protective Agents; Tretinoin	2011
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:5 Topics: Dermatologic Agents; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Quality of Life; Recurrence; Severity of Illness Index; Surveys and Questionnaires; Tretinoin	2012
Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. Archives of dermatology, 2011, Volume: 147, Issue:9 Topics: Adult; Bleaching Agents; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Lasers, Dye; Melanosis; Middle Aged; Patient Satisfaction; Single-Blind Method; Tretinoin	2011
Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma. Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:3 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Middle Aged; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Tretinoin; Young Adult	2013
Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:1 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Chemotherapy, Adjuvant; Cryotherapy; Drug Combinations; Erythema; Female; Fluocinolone Acetonide; Hand Dermatoses; Humans; Hydroquinones; Lentigo; Male; Melanins; Middle Aged; Prospective Studies; Single-Blind Method; Skin Cream; Sunlight; Tretinoin	2015
Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination. Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:4 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Drug Therapy, Combination; Erythema; Fluocinolone Acetonide; Humans; Hydroquinones; Keratolytic Agents; Long-Term Care; Maintenance Chemotherapy; Melanins; Melanosis; Prospective Studies; Single-Blind Method; Skin; Skin Pigmentation; Tretinoin; Young Adult	2014
Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study. Clinical drug investigation, 2015, Volume: 35, Issue:6 Topics: Adolescent; Adult; Asian People; Double-Blind Method; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Tretinoin; Young Adult	2015
Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma. Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:3 Topics: Adult; Asian People; Combined Modality Therapy; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Lasers, Solid-State; Melanosis; Middle Aged; Ointments; Prospective Studies; Single-Blind Method; Treatment Outcome; Tretinoin	2020
Topical metformin in the treatment of melasma: A preliminary clinical trial. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Metformin; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Skin Lightening Preparations; Skin Pigmentation; Treatment Outcome; Tretinoin; Young Adult	2020
Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:6 Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Prospective Studies; Severity of Illness Index; Sunscreening Agents; Tranexamic Acid; Treatment Outcome; Tretinoin; Young Adult	2020

Other Studies

31 other study(ies) available for fluocinolone acetonide and tretinoin

Article	Year
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer research, 1988, Jun-15, Volume: 48, Issue:12 Topics: Animals; Bucladesine; Cell Communication; Cell Transformation, Neoplastic; Cells, Cultured; Dexamethasone; Fluocinolone Acetonide; Intercellular Junctions; Mice; Mice, Inbred BALB C; Tretinoin	1988
Tumor-promoting phorbol esters cause a stable reduction of dermal collagen in mouse skin. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:7 Topics: Animals; Calcimycin; Cell Division; Collagen; Female; Fluocinolone Acetonide; Mice; Phorbol Esters; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin	1987
Modulation of chrysarobin skin tumor promotion. Carcinogenesis, 1988, Volume: 9, Issue:8 Topics: Animals; Anthracenes; Carcinogens; Cocarcinogenesis; Eflornithine; Female; Fluocinolone Acetonide; Mice; Ornithine Decarboxylase; Papilloma; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin	1988
Murine epidermal xanthine oxidase activity: correlation with degree of hyperplasia induced by tumor promoters. Cancer research, 1987, Dec-01, Volume: 47, Issue:23 Topics: Animals; Carcinogens; Epidermis; Female; Fluocinolone Acetonide; Mice; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin; Xanthine Oxidase	1987
Two-stage tumor promotion in mouse skin: an alternative interpretation. Journal of the National Cancer Institute, 1985, Volume: 74, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cocarcinogenesis; Croton Oil; Fluocinolone Acetonide; Mice; Mice, Inbred Strains; Papilloma; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin	1985
Effects of 12-O-tetradecanoylphorbol-13-acetate and retinoids on intercellular junctional communication measured with a citrulline incorporation assay. Carcinogenesis, 1985, Volume: 6, Issue:4 Topics: Animals; Argininosuccinate Lyase; Argininosuccinate Synthase; Argininosuccinic Aciduria; Cell Communication; Cell Line; Cells, Cultured; Citrulline; Cricetinae; Cricetulus; Dimethyl Sulfoxide; Fibroblasts; Fluocinolone Acetonide; Intercellular Junctions; Phorbols; Tetradecanoylphorbol Acetate; Tretinoin	1985
The effect of topical drugs on mouse ear epidermal transglutaminase activity. The Journal of investigative dermatology, 1982, Volume: 79, Issue:3 Topics: Administration, Topical; Animals; Anthracenes; Anthralin; Clinical Enzyme Tests; DNA; Ear; Epidermis; Female; Fluocinolone Acetonide; gamma-Glutamyltransferase; Growth; Mice; Proteins; Skinfold Thickness; Time Factors; Tretinoin	1982
Effects of inhibitors of tumor promotion on 12-O-tetradecanoylphorbol-13-acetate-induced keratin modification in mouse epidermis. Carcinogenesis, 1982, Volume: 3, Issue:11 Topics: Animals; Carcinogens; Cycloheximide; Electrophoresis, Polyacrylamide Gel; Epidermis; Female; Fluocinolone Acetonide; Hyperplasia; Keratins; Mice; Molecular Weight; Phorbols; Skin; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin	1982
Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne. The Journal of investigative dermatology, 1984, Volume: 83, Issue:5 Topics: Acne Vulgaris; Animals; Benzoyl Peroxide; Disease Models, Animal; Erythromycin; Female; Fluocinolone Acetonide; Inflammation; Injections, Intradermal; Naproxen; Propionibacterium acnes; Pyrazoles; Rats; Rats, Inbred Strains; Tetracycline; Tretinoin	1984
The relevance of gap junctions to stage I tumor promotion in mouse epidermis. Carcinogenesis, 1984, Volume: 5, Issue:12 Topics: Animals; Cell Communication; Diterpenes; Dose-Response Relationship, Drug; Female; Fluocinolone Acetonide; Intercellular Junctions; Mice; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin	1984
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Diterpenes; Epidermal Cells; Female; Fluocinolone Acetonide; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Phorbol Esters; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin	1980
Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice. Proceedings of the National Academy of Sciences of the United States of America, 1981, Volume: 78, Issue:4 Topics: Animals; Animals, Newborn; Binding, Competitive; Caenorhabditis elegans Proteins; Carrier Proteins; Epidermis; Fluocinolone Acetonide; Kinetics; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phorbols; Protein Kinase C; Receptors, Drug; Tretinoin	1981
Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism. Carcinogenesis, 1995, Volume: 16, Issue:9 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Base Sequence; Carcinogens; Cell Division; Drug Interactions; Ear, External; Edema; Female; Fluocinolone Acetonide; Genes, ras; Genotype; Mice; Mice, Inbred Strains; Mirex; Molecular Sequence Data; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin	1995
Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis, 1995, Volume: 16, Issue:4 Topics: Animals; Anticarcinogenic Agents; Cell Transformation, Neoplastic; Cells, Cultured; Colforsin; Cyclic AMP; Drug Resistance; Fluocinolone Acetonide; Glucocorticoids; Mice; Phenotype; Sensitivity and Specificity; Skin; Skin Neoplasms; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Tretinoin	1995
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proceedings of the National Academy of Sciences of the United States of America, 1994, Jan-18, Volume: 91, Issue:2 Topics: Animals; Base Sequence; Binding Sites; Cell Line; Cell Transformation, Neoplastic; DNA; Epidermal Growth Factor; Fluocinolone Acetonide; Gene Expression; Genes, fos; Genes, jun; Genes, Reporter; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Proto-Oncogene Proteins c-jun; Skin; Tetradecanoylphorbol Acetate; Transfection; Tretinoin	1994
Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proceedings of the National Academy of Sciences of the United States of America, 1997, May-27, Volume: 94, Issue:11 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Female; Fluocinolone Acetonide; Luciferases; Male; Mice; Mice, Transgenic; Papilloma; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Retinoids; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation; Tretinoin	1997
Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis, 1999, Volume: 20, Issue:9 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Calcimycin; Calcium; Carcinogens; Cocarcinogenesis; Diglycerides; Diterpenes; Enzyme Activation; Enzyme Induction; Epidermis; Female; Fluocinolone Acetonide; Gene Expression Regulation; Glutaredoxins; Glutathione; Ionophores; Mice; Oxidation-Reduction; Oxidoreductases; Phorbol Esters; Protein Kinase C; Proteins; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Thioredoxin-Disulfide Reductase; Thioredoxins; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin	1999
Transactivation of RARE and GRE in the cellular response to arsenic. Molecular and cellular biochemistry, 2001, Volume: 222, Issue:1-2 Topics: Animals; Antineoplastic Agents; Arsenates; Arsenic; Arsenites; Cell Differentiation; Cell Line; Drug Synergism; Epidermal Cells; Fluocinolone Acetonide; Genes, Reporter; Glucocorticoids; Luciferases; Mice; Response Elements; Transcriptional Activation; Transfection; Tretinoin	2001
Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. The British journal of dermatology, 2006, Volume: 156 Suppl 1 Topics: Administration, Topical; Drug Therapy, Combination; Facial Dermatoses; Fluocinolone Acetonide; Glucocorticoids; Hispanic or Latino; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Latin America; Salicylic Acid; Skin Pigmentation; Tretinoin	2006
Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. The British journal of dermatology, 2006, Volume: 156 Suppl 1 Topics: Adult; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Language; Male; Melanosis; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Tretinoin	2006
An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma. Cutis, 2007, Volume: 80, Issue:6 Topics: Administration, Topical; Adult; Antioxidants; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Middle Aged; Treatment Outcome; Tretinoin; Vitamin A	2007
Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:4 Topics: Acanthosis Nigricans; Administration, Topical; Adult; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Treatment Outcome; Tretinoin	2009
Hyperpigmentation: old problem, new therapies. Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:9 Topics: Chemexfoliation; Dermatologic Agents; Dicarboxylic Acids; Fluocinolone Acetonide; Humans; Hydroquinones; Hyperpigmentation; Laser Therapy; Tretinoin	2009
Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States. The Journal of dermatological treatment, 2010, Volume: 21, Issue:5 Topics: Administration, Cutaneous; Clinical Trials as Topic; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Costs; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Ointments; Treatment Outcome; Tretinoin; United States	2010
Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:6 Topics: Administration, Topical; Adolescent; Adult; Aged; Drug Administration Schedule; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Skin Pigmentation; Tretinoin; Young Adult	2010
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:1 Topics: Administration, Topical; Antioxidants; Combined Modality Therapy; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Lasers, Solid-State; Melanosis; Tretinoin	2011
Triple combination and glycolic acid peels in melasma in Indian patients. Journal of cosmetic dermatology, 2011, Volume: 10, Issue:1 Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antioxidants; Chemexfoliation; Drug Combinations; Face; Female; Fluocinolone Acetonide; Glycolates; Humans; Hydroquinones; India; Keratolytic Agents; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin; Young Adult	2011
Detection of hydroquinone by Raman spectroscopy in patients with melasma before and after treatment. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2019, Volume: 25, Issue:1 Topics: Adult; Drug Monitoring; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Precision Medicine; Skin; Skin Lightening Preparations; Spectrum Analysis, Raman; Treatment Outcome; Tretinoin; Young Adult	2019
Microneedling with Drug Delivery (Hydroquinone 4% Serum) as an Adjuvant Therapy for Recalcitrant Melasma. Skinmed, 2020, Volume: 18, Issue:1 Topics: Adult; Combined Modality Therapy; Cosmetic Techniques; Dermatologic Agents; Drug Delivery Systems; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Needles; Quality of Life; Sunscreening Agents; Treatment Outcome; Tretinoin	2020
Perspectives of topical formulations for melasma. International journal of dermatology, 2023, Volume: 62, Issue:2 Topics: Female; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Retinoids; Sunscreening Agents; Treatment Outcome; Tretinoin	2023